Accession Number: | 0001209191-20-016081 |
Date: | 2020-03-02 |
Issuer: | ACLARIS THERAPEUTICS, INC. (ACRS) |
Original Submission Date: |
MEHRA ANAND
C/O ACLARIS THERAPEUTICS, INC.
640 LEE ROAD, SUITE 200
WAYNE, PA 19087
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-03-02 | M | 8,876 | a | $0.00 | 8,876 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2020-03-02 | deemed execution date | A | 8,876 (a) | common stock 8,876 | $0.00 | 8,876 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-03-02 | deemed execution date | M | 8,876 (d) | common stock 8,876 | $0.00 | 0 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. |
f2 | the shares underlying these restricted stock units vest immediately. |